AgeX Therapeutics, Inc. (24) | Business Finance (19)
Browse by Subcategory
Recent Contracts
-
Amendment No. 3 to Registration Rights Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited
(Filed With SEC on February 15, 2022)
-
Warrant Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited
(Filed With SEC on February 15, 2022)
-
Security Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited
(Filed With SEC on February 15, 2022)
-
Secured Note dated February 14, 2022, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
(Filed With SEC on February 15, 2022)
-
Amendment No. 2 to Loan Facility Agreement, dated November 8, 2021, between AgeX Therapeutics, Inc. and Juvenescence Limited
(Filed With SEC on November 9, 2021)
-
Second Amendment to Secured Convertible Facility Agreement, dated November 12, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited
(Filed With SEC on November 16, 2020)
-
Form of Warrant
(Filed With SEC on February 15, 2022)
-
Amendment No. 2 to Registration Rights Agreement, dated February 10, 2021, between AgeX Therapeutics, Inc. and Juvenescence Limited
(Filed With SEC on February 11, 2021)
-
Amendment No. 1 to Loan Facility Agreement, dated February 10, 2021, between AgeX Therapeutics, Inc. and Juvenescence Limited
(Filed With SEC on February 11, 2021)
-
First Amendment to Warrant Agreement, dated July 21, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited, including form of warrant
(Filed With SEC on August 14, 2020)
-
First Amendment to Secured Convertible Facility Agreement, dated July 21, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited
(Filed With SEC on August 14, 2020)
-
Amendment No. 1 to Registration Rights Agreement, dated March 30, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited
(Filed With SEC on March 30, 2020)
-
Warrant Agreement, dated March 30, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited, including form of warrant
(Filed With SEC on March 30, 2020)
-
Secured Convertible Facility Agreement, dated March 30, 2020, by and among AgeX Therapeutics, Inc., ReCyte Therapeutics, Inc., Reverse Bioengineering, Inc., and Juvenescence...
(Filed With SEC on March 30, 2020)
-
Warrant dated August 13, 2019
(Filed With SEC on August 14, 2019)
-
Registration Rights Agreement, dated August 13, 2019, between AgeX Therapeutics, Inc. and Juvenescence, Ltd
(Filed With SEC on August 14, 2019)
-
Warrant Agreement, dated August 13, 2019, between AgeX Therapeutics, Inc. and Juvenescence, Ltd
(Filed With SEC on August 14, 2019)
-
Loan Facility Agreement, dated August 13, 2019, between AgeX Therapeutics, Inc. and Juvenescence, Ltd
(Filed With SEC on August 14, 2019)
-
Warrant Agreement, dated February 28, 2018, including form of warrant
(Filed With SEC on April 1, 2019)